Hollander E, Allen A. Beauty is in the eye of the beholder: new insights in imagined ugliness. Primary Psychiatry. July 2006; 13(7):37-8.

Hadley SJ, Kim S, Priday L, Hollander E. Pharmacologic treatment of body Dysmorphic disorder. Primary Psychiatry. July 2006; 13(7):61-69.

Buchsbaum MS, Hollander E, Pallanti S, Baldini Rossi N, Platholi J, Newmark R, Bloom R, Sood E. Positron emission tomography imaging of risperidone augmentation in erotonin reuptake inhibitor-refractory patients. Neuropsychobiology. May 2006; 53(3): 157-168.

Bartz JA, Hollander E. Is obsessive-compulsive disorder an anxiety disorder? Prog Neuropsychopharmacol Biol Psychiatry. May 2006; 30(3): 338-352.

Rosario-Campos MC et al. The dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions. Mol Psychiatry. May 2006; 11(5): 495-504.

Grant JE, Potenza MN, Hollander E, Cunningham-Williams R, Nurminen T, Smits G, Kallio A. Mulitcenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am J Psychiatry. Feb 2006; 163(2): 303-312.

Hollander E et al. Serotonin-norepinephrine reuuptake inhibitors in the treatment of obsessive-compulsive disorder: a critical review. J Clin Psychiaty. 2006; 67(4):600-610.

Hollander E, Dell'Osso B. Topiramate plus paroxetine in treatment-resistant obsessive-compulsive disorder. Int Clin Psychopharmacol. 2006; 21(3):189-191.

Dell'Osso B, Nestadt G, Allen A, Hollander E. Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: a critical review. J Clin Psychiatry. 2006; 67:600-610.

Simeon D, Knutelska M, Smith L, Baker BR, Hollander E. A preliminary study of cortisol and norepinephrine reactivity to psychosocial stress in borderline personality disorder with high and low dissociation. Psychiatric Res. (in press).

Hollander E, Baker BR, Kahn J, Stein DJ. Conceptualizing and assessing impulse-control disorders. In Hollander E, Stein DJ (editors): Clinical Manual of Impulse Control Disorders. American Psychiatric Publishing, Inc., Washington, DC. 2006; pp. 1-18.

Dell'Osso B, Allen A, Hollander E. Comorbidity issues in the pharmacological treatment of pathological gambling: a critical review. Clin Pract Epidemol Ment Health. 2005 Oct 10; 1:21.

Dell'Osso B, Allen A, Hollander E. Fluvoxamine: a selective serotonin re-uptake inhibitor for the treatment of obsessive-compulsive disorder. Expert Opin Pharmacother. 2005; 6(15):2727-40.

Hollander E, Sood E, Pallanti S, Baldini-Rossi N, Baker B. Pharmacological treatments of pathological gambling. J Gambling Studies. 2005; 21(1):101-110.

Hollander E, Pallanti S, Baldini Rossi N, Sood E, Baker BR, Buchsbaum M. Imaging monetary reward in pathological gamblers. World J Biol Psychiatry. 2005; 6(2):113-120.

Hollander E, Sood E, Pallanti S, Baldini-Rossi, N, Baker B. Pharmacological treatments of pathological gambling. J Gambl Stud. 2005; 21(1):101-110.

Hollander E, Pallanti S, Allen A, Sood E, Baldini-Rossi N. Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders? Am J Psychiatry. 2005; 162(1):137-45.

Hollander E, Allen A, Steiner M, Wheadon DE, Oakes R, Burnham D; Paroxetine OCD Study Group. Acute and long-term treatment and prevention of relapse of obsessive-compulsive disorder with paroxetine. J Clin Psychiatry. 2003; 64:1113-1121.

Hollander E, Rossi NB, Sood E, Pallanti S. Risperidone augmentation in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. Int J Neuropsychopharmacol. 2003; 6:397-401.

Hollander E, Friedberg J, Wasserman S, Allen A, Birnbaum M, Koran LM. Venlafaxine in treatment-resistant obsessive-compulsive disorder. J Clin Psychiatry. 2003; 64:546-550. Erratum in: J Clin Psychiatry. 2003; 4:972.

Sood ED, Pallanti S, Hollander E. Diagnosis and treatment of pathologic gambling. Curr Psychiatry Rep. 2003; 5:9-15.

Sood ED, Pallanti S, Hollander E. Serotonin reuptake inhibitors in the treatment of pathological gambling. Essent Psychopharmacol. 2003; 5:157-169.

Pallanti S, Baldini Rossi N, Sood E, Hollander E. Nefazodone treatment of pathological gambling: a prospective open-label controlled trial. J Clin Psychiatry. 2002; 63:1034-1039.

Pallanti S, Quercioli, L, Sood E, Hollander E. Lithium and valproate treatment of pathological gambling: a randomized single-blind study. J Clin Psychiatry. 2002; 63(7):559-564.

Hadley SJ, Greenberg J, Hollander E. Diagnosis and treatment of body dysmorphic disorder in adolescents. Curr Psychiatry Rep. 2002; 4:108-113.

Hollander E, Kaplan A, Allen A, Cartwright C. Pharmacotherapy for obsessive-compulsive disorder. In Hollander E and Allen A (eds.) The Psychiatric Clinics of North America: Obsessive-Compulsive Spectrum Disorders, Philadelphia, PA, W.B. Saunders Co., Vol. 23, No. 3, September 2000, pp. 643-656.

Hollander E, Buchalter AJ, DeCaria CM. Pathological gambling. In Hollander E and Allen A (eds.) The Psychiatric Clinics of North America: Obsessive-Compulsive Spectrum Disorders, Philadelphia, PA, W.B. Saunders Co., Vol. 23, No. 3, September 2000, pp. 629-642.

Allen A, Hollander E. Body dysmorphic disorder. In Hollander E and Allen A (eds.) The Psychiatric Clinics of North America: Obsessive-Compulsive Spectrum Disorders, Philadelphia, PA, W.B. Saunders Co., Vol. 23, No. 3, September 2000, pp. 617-628.

Hollander E, Kaplan A, Schmeidler J, Yang H, Li D, Koran LM, Barbato LM. Neurological soft signs as predictors of treatment response to selective serotonin reuptake inhibitors in obsessive-compulsive disorder. J Neuropsy Clin Neurosci. 2005; 17(4):472-77.

Hollander E, Greenberg J. Pharmacological treatment of the impulsive-aggression symptom domain in borderline personality disorder. Psychiatric Times, suppl., 1-4.

Allen A, Hollander E. Psychopharmacological treatments for body image disturbances. In Body Image: A Handbook of Theory, Research, and Clinical Practice. Cash TF, Pruzinsky T, eds. New York: The Guilford Press, 2002, p. 450-458.

Hadley SJ, Newcorn JH, Hollander E. The neurobiology and psychopharmacology of body dysmorphic disorder. In Disorders of Body Image, Castle DJ, Phillips KA, eds., Wrightson Biomedical Publishing, Ltd., Philadelphia, 2002.

Allen A, Hollander E. Psychopharmacological treatments of body image disturbances. In Body Image: A Handbook of Theory, Research, and Clinical Practice, Cash TF and Pruzinsky T, eds. New York: The Guilford Press, 2002.

Hollander E, Allen A. Serotonergic drugs and the treatment of disorders related to obsessive-compulsive disorder. In Pato MT and Zohar J Current Treatments of Obsessive-Compulsive Disorder, 2nd Edition. Washington, D.C., American Psychiatric Publishing, Inc., 2001, pp. 193-220.